Literature DB >> 26240353

Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma.

Marco Santoro1, Salah-Eddine Lamhamedi-Cherradi2, Brian A Menegaz2, Joseph A Ludwig3, Antonios G Mikos4.   

Abstract

Three-dimensional tumor models accurately describe different aspects of the tumor microenvironment and are readily available for mechanistic studies of tumor biology and for drug screening. Nevertheless, these systems often overlook biomechanical stimulation, another fundamental driver of tumor progression. To address this issue, we cultured Ewing sarcoma (ES) cells on electrospun poly(ε-caprolactone) 3D scaffolds within a flow perfusion bioreactor. Flow-derived shear stress provided a physiologically relevant mechanical stimulation that significantly promoted insulin-like growth factor-1 (IGF1) production and elicited a superadditive release in the presence of exogenous IGF1. This finding is particularly relevant, given the central role of the IGF1/IGF-1 receptor (IGF-1R) pathway in ES tumorigenesis and as a promising clinical target. Additionally, flow perfusion enhanced in a rate-dependent manner the sensitivity of ES cells to IGF-1R inhibitor dalotuzumab (MK-0646) and showed shear stress-dependent resistance to the IGF-1R blockade. This study demonstrates shear stress-dependent ES cell sensitivity to dalotuzumab, highlighting the importance of biomechanical stimulation on ES-acquired drug resistance to IGF-1R inhibition. Furthermore, flow perfusion increased nutrient supply throughout the scaffold, enriching ES culture over static conditions. Our use of a tissue-engineered model, rather than human tumors or xenografts, enabled precise control of the forces experienced by ES cells, and therefore provided at least one explanation for the remarkable antineoplastic effects observed by some ES tumor patients from IGF-1R targeted therapies, in contrast to the lackluster effect observed in cells grown in conventional monolayer culture.

Entities:  

Keywords:  biological therapy; mechanical stimulation; tissue engineering; tumor model

Mesh:

Substances:

Year:  2015        PMID: 26240353      PMCID: PMC4547215          DOI: 10.1073/pnas.1506684112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Design of a high-throughput flow perfusion bioreactor system for tissue engineering.

Authors:  Rebecca L Dahlin; Ville V Meretoja; Mengwei Ni; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part C Methods       Date:  2012-05-09       Impact factor: 3.056

Review 2.  Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer.

Authors:  Mario Scartozzi; Maristella Bianconi; Elena Maccaroni; Riccardo Giampieri; Rossana Berardi; Stefano Cascinu
Journal:  Curr Opin Mol Ther       Date:  2010-06

3.  Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds.

Authors:  A S Goldstein; T M Juarez; C D Helmke; M C Gustin; A G Mikos
Journal:  Biomaterials       Date:  2001-06       Impact factor: 12.479

Review 4.  Ewing's sarcoma: standard and experimental treatment options.

Authors:  Vivek Subbiah; Pete Anderson; Alexander J Lazar; Emily Burdett; Kevin Raymond; Joseph A Ludwig
Journal:  Curr Treat Options Oncol       Date:  2009-06-17

Review 5.  Taking the study of cancer cell survival to a new dimension.

Authors:  Tyler Jacks; Robert A Weinberg
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

Review 6.  Mechanotransduction gone awry.

Authors:  Diana E Jaalouk; Jan Lammerding
Journal:  Nat Rev Mol Cell Biol       Date:  2009-01       Impact factor: 94.444

7.  Anabolic effects of IGF-1 signaling on the skeleton.

Authors:  Candice G T Tahimic; Yongmei Wang; Daniel D Bikle
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-04       Impact factor: 5.555

8.  Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines.

Authors:  Paolo Romano; Assunta Manniello; Ottavia Aresu; Massimiliano Armento; Michela Cesaro; Barbara Parodi
Journal:  Nucleic Acids Res       Date:  2008-10-15       Impact factor: 16.971

9.  IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.

Authors:  Luisa Cironi; Nicolò Riggi; Paolo Provero; Natalie Wolf; Mario-Luca Suvà; Domizio Suvà; Vincent Kindler; Ivan Stamenkovic
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

10.  Dual targeting of the insulin-like growth factor and collateral pathways in cancer: combating drug resistance.

Authors:  Joseph A Ludwig; Salah-Eddine Lamhamedi-Cherradi; Ho-Young Lee; Aung Naing; Robert Benjamin
Journal:  Cancers (Basel)       Date:  2011-07-26       Impact factor: 6.639

View more
  33 in total

Review 1.  Heralding a new paradigm in 3D tumor modeling.

Authors:  Eliza L S Fong; Daniel A Harrington; Mary C Farach-Carson; Hanry Yu
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

Review 2.  Towards rationally designed biomanufacturing of therapeutic extracellular vesicles: impact of the bioproduction microenvironment.

Authors:  Divya B Patel; Marco Santoro; Louis J Born; John P Fisher; Steven M Jay
Journal:  Biotechnol Adv       Date:  2018-09-12       Impact factor: 14.227

3.  Modeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma.

Authors:  Marco Santoro; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Eric R Molina; Danielle Wu; Waldemar Priebe; Joseph A Ludwig; Antonios G Mikos
Journal:  Tissue Eng Part A       Date:  2017-01       Impact factor: 3.845

Review 4.  Mesenchymal stem cell cultivation in electrospun scaffolds: mechanistic modeling for tissue engineering.

Authors:  Ágata Paim; Isabel C Tessaro; Nilo S M Cardozo; Patricia Pranke
Journal:  J Biol Phys       Date:  2018-03-05       Impact factor: 1.365

5.  Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments.

Authors:  Manuele G Muraro; Simone Muenst; Valentina Mele; Luca Quagliata; Giandomenica Iezzi; Alexandar Tzankov; Walter P Weber; Giulio C Spagnoli; Savas D Soysal
Journal:  Oncoimmunology       Date:  2017-05-30       Impact factor: 8.110

6.  Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma.

Authors:  Eric R Molina; Letitia K Chim; Sergio Barrios; Joseph A Ludwig; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2020-02-14       Impact factor: 6.389

Review 7.  Emerging Roles of Electrospun Nanofibers in Cancer Research.

Authors:  Shixuan Chen; Sunil Kumar Boda; Surinder K Batra; Xiaoran Li; Jingwei Xie
Journal:  Adv Healthc Mater       Date:  2017-12-06       Impact factor: 9.933

8.  IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Brian A Menegaz; Vandhana Ramamoorthy; Deeksha Vishwamitra; Ying Wang; Rebecca L Maywald; Adriana S Buford; Izabela Fokt; Stanislaw Skora; Jing Wang; Aung Naing; Alexander J Lazar; Eric M Rohren; Najat C Daw; Vivek Subbiah; Robert S Benjamin; Ravin Ratan; Waldemar Priebe; Antonios G Mikos; Hesham M Amin; Joseph A Ludwig
Journal:  J Natl Cancer Inst       Date:  2016-08-30       Impact factor: 13.506

9.  Biomechanical forces in tissue engineered tumor models.

Authors:  Letitia K Chim; Antonios G Mikos
Journal:  Curr Opin Biomed Eng       Date:  2018-03-26

10.  Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma.

Authors:  Eric R Molina; Letitia K Chim; Maria C Salazar; Shail M Mehta; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Tejus Satish; Sana Mohiuddin; David McCall; Ana Maria Zaske; Branko Cuglievan; Alexander J Lazar; David W Scott; Jane K Grande-Allen; Joseph A Ludwig; Antonios G Mikos
Journal:  Acta Biomater       Date:  2019-09-19       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.